162 related articles for article (PubMed ID: 36544211)
1. The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial.
Ahlin R; Nybacka S; Josefsson A; Stranne J; Steineck G; Hedelin M
Trials; 2022 Dec; 23(1):1041. PubMed ID: 36544211
[TBL] [Abstract][Full Text] [Related]
2. Effects on Serum Hormone Concentrations after a Dietary Phytoestrogen Intervention in Patients with Prostate Cancer: A Randomized Controlled Trial.
Ahlin R; Nørskov NP; Nybacka S; Landberg R; Skokic V; Stranne J; Josefsson A; Steineck G; Hedelin M
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049632
[TBL] [Abstract][Full Text] [Related]
3. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
Hedelin M; Bälter KA; Chang ET; Bellocco R; Klint A; Johansson JE; Wiklund F; Thellenberg-Karlsson C; Adami HO; Grönberg H
Prostate; 2006 Oct; 66(14):1512-20. PubMed ID: 16921512
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment.
Stettner M; Kaulfuss S; Burfeind P; Schweyer S; Strauss A; Ringert RH; Thelen P
Mol Cancer Ther; 2007 Oct; 6(10):2626-33. PubMed ID: 17913855
[TBL] [Abstract][Full Text] [Related]
6. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML
Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines.
Adjakly M; Ngollo M; Lebert A; Dagdemir A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
Nutr Cancer; 2014; 66(3):474-82. PubMed ID: 24641702
[TBL] [Abstract][Full Text] [Related]
8. Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats.
Weber KS; Setchell KD; Stocco DM; Lephart ED
J Endocrinol; 2001 Sep; 170(3):591-9. PubMed ID: 11524239
[TBL] [Abstract][Full Text] [Related]
9. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
Hedelin M; Klint A; Chang ET; Bellocco R; Johansson JE; Andersson SO; Heinonen SM; Adlercreutz H; Adami HO; Grönberg H; Bälter KA
Cancer Causes Control; 2006 Mar; 17(2):169-80. PubMed ID: 16425095
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer).
Scheinberg T; Kench J; Stockler M; Mahon KL; Sebastian L; Stricker P; Joshua AM; Woo H; Thanigasalam R; Ahmadi N; Centenera MM; Butler LM; Horvath LG
BMJ Open; 2020 Jan; 10(1):e033667. PubMed ID: 31988233
[TBL] [Abstract][Full Text] [Related]
11. Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.
Hamilton-Reeves JM; Banerjee S; Banerjee SK; Holzbeierlein JM; Thrasher JB; Kambhampati S; Keighley J; Van Veldhuizen P
PLoS One; 2013; 8(7):e68331. PubMed ID: 23874588
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostate.
Wu WF; Wang L; Spetsieris N; Boukovala M; Efstathiou E; Brössner C; Warner M; Gustafsson JA
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33771918
[TBL] [Abstract][Full Text] [Related]
13. Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.
Bosland MC; Kato I; Zeleniuch-Jacquotte A; Schmoll J; Enk Rueter E; Melamed J; Kong MX; Macias V; Kajdacsy-Balla A; Lumey LH; Xie H; Gao W; Walden P; Lepor H; Taneja SS; Randolph C; Schlicht MJ; Meserve-Watanabe H; Deaton RJ; Davies JA
JAMA; 2013 Jul; 310(2):170-8. PubMed ID: 23839751
[TBL] [Abstract][Full Text] [Related]
14. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice.
Bylund A; Zhang JX; Bergh A; Damber JE; Widmark A; Johansson A; Adlercreutz H; Aman P; Shepherd MJ; Hallmans G
Prostate; 2000 Mar; 42(4):304-14. PubMed ID: 10679760
[TBL] [Abstract][Full Text] [Related]
15. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
Vergis R; Corbishley CM; Norman AR; Bartlett J; Jhavar S; Borre M; Heeboll S; Horwich A; Huddart R; Khoo V; Eeles R; Cooper C; Sydes M; Dearnaley D; Parker C
Lancet Oncol; 2008 Apr; 9(4):342-51. PubMed ID: 18343725
[TBL] [Abstract][Full Text] [Related]
17. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
Eastham JA; Kelly WK; Grossfeld GD; Small EJ;
Urology; 2003 Dec; 62 Suppl 1():55-62. PubMed ID: 14747042
[TBL] [Abstract][Full Text] [Related]
18. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
19. Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women.
Hedelin M; Löf M; Olsson M; Adlercreutz H; Sandin S; Weiderpass E
J Nutr; 2008 May; 138(5):938-45. PubMed ID: 18424605
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.
Chae YK; Huang HY; Strickland P; Hoffman SC; Helzlsouer K
PLoS One; 2009 Aug; 4(8):e6523. PubMed ID: 19654868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
